Protective potential of Cynara scolymus extract in thioacetamide model of hepatic injury in rats
Open Access
- 15 May 2021
- journal article
- research article
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (2) , 1792-1802
Abstract
Hepatic injury is a worldwide health problem. This study aimed to evaluate the possible hepatoprotective potential of Artichoke (Cynara scolymus) extract (CSE) in albino rats using the thioacetamide (TAA) a model of liver injury. Acclimatized 42 rats were divided randomly into seven groups, each consists of six rats, and subjected to different treatments. Hepatic injury model was induced by administration of TAA at a dose of 100 mg per kg, intraperitoneally, twice weekly for 8 weeks (+ve control); test groups rats received CSE at doses of 100 or 200 mg/kg BW, orally, daily for 8 weeks adjunct with TAA; standard group rats received Silymarin at a dose of 100 mg per kg, orally, daily for 8 weeks adjunct with TAA; other 2 groups of rats received only CSE at the same dose levels; while -ve control rats received only the vehicles. Blood and liver tissue samples were collected at the end of the experimental course for different assessments. Results revealed that CSE exhibited dose-dependent hepatoprotection indicated by nearly normalized parameters, including enzymatic liver function parameters (AST, ALT, GGT & ALP with potential % of 94.06, 86.96, 85.93, 64.85, respectively, after large dose when standardized by Silymarin); non-enzymatic parameters (total protein, albumin, globulins, total bilirubin, conjugated bilirubin, unconjugated bilirubin, TAGs, Cholesterol, HDL, LDL & VLDL with potential % of 83.42, 85.9, 83.44, 98.1, 77.41, 91.5, 97.51, 97.46, 81.41, 88.52 & 89.4, respectively, after large dose when standardized by Silymarin). The underlying mechanism of the observed hepatoprotection of CSE was attributed to impeding the oxidative stress-mediated by TAA, indicated by reduced hepatocyte lipid peroxidation product MDA (95.96 % of Silymarin), and improved antioxidative enzymes in liver homogenate, namely, GPx, Catalase & SOD with potentials of 95.44, 87.02 & 81.48 % of Silymarin, respectively. Macroscopic and microscopic pathological pictures were supportive to the biochemical findings, where the pathological lesions caused by TAA as congestion and dilatation of central and portal veins with perivascular fibrous connective tissue proliferation admixed with few mononuclear leukocytes plus necrotic hepatocytes and hyperplastic biliary epithelium, were ameliorated dose-dependently when CSE was administered together with TAA. The present study's data may suggest CSE as a natural source for promising hepatoprotective and antioxidant drug preparations.Keywords
This publication has 37 references indexed in Scilit:
- Circulating microRNAs, potential biomarkers for drug-induced liver injuryProceedings of the National Academy of Sciences, 2009
- Origins of Dye-Binding Methods for Measuring Serum AlbuminClinical Chemistry, 2009
- Liver cirrhosisThe Lancet, 2008
- Preparation of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogsInternational Journal of Pharmaceutics, 2006
- Phenolic Compounds from the Leaf Extract of Artichoke (Cynara scolymus L.) and Their Antimicrobial ActivitiesJournal of Agricultural and Food Chemistry, 2004
- Improved method for identification and determination of .epsilon.-(.gamma.-glutamyl)lysine cross-link in protein using proteolytic digestion and derivatization with phenyl isothiocyanate followed by high-performance liquid chromatography separationJournal of Agricultural and Food Chemistry, 1992
- Optimization of assay conditions for, and the selected tissue distribution of, alanine aminotransferase and aspartate aminotransferase of English sole, Parophrys vetulus GirardJournal of Fish Biology, 1982
- Inefficiency of cynarin as therapeutic regimen in familial type ii hyperlipoproteinaemiaAtherosclerosis, 1977
- The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygenBiochemical and Biophysical Research Communications, 1972
- Assay of Plasma Antihaemophilic Globulin (AHG)*British Journal of Haematology, 1959